OTCMKTS:ELXMF Nova Eye Medical (ELXMF) Stock Price, News & Analysis → The Only Energy Play You Should Be Looking At (From Wealthpin Pro) (Ad) Free ELXMF Stock Alerts $0.10 0.00 (0.00%) (As of 05/12/2023) Add Compare Share Share Today's Range$0.10▼$0.1050-Day Range$0.10▼$0.1052-Week Range$0.10▼$0.19VolumeN/AAverage Volume75,600 shsMarket CapitalizationN/AP/E Ratio13.70Dividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Nova Eye Medical alerts: Email Address Ad Crypto 101 Media[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Did you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. About Nova Eye Medical Stock (OTCMKTS:ELXMF)Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. It offers iTrack, a glaucoma surgical device to reduce intraocular pressure in adult patients with open-angle glaucoma; iTrack Advance, a canaloplasty microcatheter; Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020. Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia.Read More ELXMF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ELXMF Stock News HeadlinesMay 1, 2024 | investing.comNova Eye Medical Ltd (EYE)December 26, 2023 | finance.yahoo.comNova Eye Medical Announces U.S. Market Clearance of the iTrack™ Advance Canaloplasty DeviceDecember 26, 2023 | finance.yahoo.comHere's Why Nova Eye Medical Limited's (ASX:EYE) CEO Compensation Is The Least Of Shareholders ConcernsSee More Headlines Receive ELXMF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nova Eye Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolOTCMKTS:ELXMF CUSIPN/A CIKN/A Webwww.ellex.com Phone61 8 7074 8200FaxN/AEmployees301Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio13.70 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Victor Previn B.E. (Age 66)B.Eng, Founder & Executive Chairman Comp: $158.24kMr. Thomas H. Spurling AM (Age 62)BSc (Hons), FRACI, FTSE, Ph.D., MD & Executive Director Comp: $168.73kLiam CookChief Financial OfficerMr. Keith ByrneVice President of Global OperationsMark FlynnInvestor RelationsMs. Kate HuntHead of MarketingDr. David Lubeck M.D.Chief Medical OfficerMr. Joaquin V. Wolff (Age 66)President of Ellex iTrack Ms. Kimberley MenziesGroup Financial Controller & Global Finance ManagerMr. Simon Jeremy Newton Gray BEc (Age 65)C.A., CA, Company Secretary More ExecutivesKey CompetitorsAinosNASDAQ:AIMDWBICO Group AB (publ)OTCMKTS:CLLKFBone BiologicsNASDAQ:BBLGWCaliber Imaging & DiagnosticsOTCMKTS:LCDXCell MedXOTCMKTS:CMXCView All Competitors ELXMF Stock Analysis - Frequently Asked Questions How have ELXMF shares performed in 2024? Nova Eye Medical's stock was trading at $0.10 at the beginning of 2024. Since then, ELXMF stock has increased by 0.0% and is now trading at $0.10. View the best growth stocks for 2024 here. How do I buy shares of Nova Eye Medical? Shares of ELXMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:ELXMF) was last updated on 6/3/2024 by MarketBeat.com Staff From Our PartnersNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemWeiss RatingsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaAre You Positioned For The New Energy Goldrush?Wealthpin ProNext President (Not Trump. Not Biden.)The Freeport SocietyCollapse of the Petrodollar Colonial Metals[Webinar] Understanding Covered CallsOICWhat’s Pelosi Buying Now?AltimetryAlex's "Next Magnificent Seven" StocksThe Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nova Eye Medical Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.